Aktis Oncology, Inc. Common stock (AKTS) — Financial Flexibility Index
Aktis Oncology, Inc. Common stock (AKTS) has a Financial Flexibility Index of -0.03x as of December 2024. Free cash flow of $-10.57 Million (operating CF $-12.80 Million minus capex $2.23 Million) represents 0% of total liabilities ($413.98 Million). Check total reinvestment intensity of Aktis Oncology, Inc. Common stock to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aktis Oncology, Inc. Common stock Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Aktis Oncology, Inc. Common stock across 21 annual periods. For the full cash flow conversion analysis, see AKTS cash flow metrics.
Annual Financial Flexibility Index for Aktis Oncology, Inc. Common stock (2014–2024)
Year-by-year free cash flow to debt coverage for Aktis Oncology, Inc. Common stock. Explore cash flow to debt ratio of Aktis Oncology, Inc. Common stock to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | $17.62 Million | $14.76 Million | $413.98 Million | ▲ +115.7% |
| 2024 | -0.27x | $-34.35 Million | $-40.35 Million | $126.83 Million | ▼ -74.1% |
| 2023 | -0.16x | $-26.24 Million | $-30.00 Million | $168.66 Million | ▲ +70.8% |
| 2023 | -0.53x | $-33.44 Million | $-44.82 Million | $62.68 Million | ▼ -431.3% |
| 2022 | -0.10x | $-15.82 Million | $-18.12 Million | $157.55 Million | ▲ +66.7% |
| 2022 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +0.0% |
| 2021 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +86.4% |
| 2021 | -2.22x | $-16.87 Million | $-29.36 Million | $7.58 Million | ▼ -486.6% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +0.0% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +34.5% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▲ +0.0% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▼ -24.7% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +0.0% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +62.9% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▲ +0.0% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▼ -122.2% |
| 2016 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +0.0% |
| 2015 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +78.7% |
| 2015 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +0.0% |
| 2014 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +97.0% |
| 2014 | -88.17x | $-26.98K | $-26.98K | $306.00 | — |